Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (141-150 of 607) with videos related to

Pageof 61
Sort By:
Arthritis and Rheumatism|August 29, 2009
Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse modelShangxi Liu, Mohit Kapoor, Christopher P Denton, et al.
Journal of Cell Communication and Signaling|April 23, 2009
Pericytes display increased CCN2 expression upon culturingXu Shiwen, Vineeth Rajkumar, Christopher P Denton, et al.
Molecular Biology of the Cell|November 17, 2017
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiationIoannis Papaioannou, Shiwen Xu, Christopher P Denton, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part II: management and therapeuticsRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Annals of the Rheumatic Diseases|July 31, 2007
Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosisS I Nihtyanova, G M Brough, C M Black, et al.
Rheumatology (Oxford, England)|August 11, 2006
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysisS I Nihtyanova, G M Brough, C M Black, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|September 27, 2013
Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trialN P Quillinan, D McIntosh, J Vernes, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimicCarolina Teles, Chiranthi Kongala Liyanage, Geoffrey Chow, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Physician-patient communication in the treatment of systemic sclerosis-associated interstitial lung disease: A narrative review and recommendationsMasataka Kuwana, Aiko Saito, Sue Farrington, et al.
Pageof 61

Showing results (141-150 of 607) with videos related to

Sort By:
Pageof 61
Arthritis and Rheumatism|August 29, 2009
Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse modelShangxi Liu, Mohit Kapoor, Christopher P Denton, et al.
Journal of Cell Communication and Signaling|April 23, 2009
Pericytes display increased CCN2 expression upon culturingXu Shiwen, Vineeth Rajkumar, Christopher P Denton, et al.
Molecular Biology of the Cell|November 17, 2017
STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiationIoannis Papaioannou, Shiwen Xu, Christopher P Denton, et al.
Journal of the American Academy of Dermatology|February 8, 2022
Systemic sclerosis in adults. Part II: management and therapeuticsRebekka Jerjen, Mandana Nikpour, Thomas Krieg, et al.
Annals of the Rheumatic Diseases|July 31, 2007
Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosisS I Nihtyanova, G M Brough, C M Black, et al.
Rheumatology (Oxford, England)|August 11, 2006
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysisS I Nihtyanova, G M Brough, C M Black, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue diseaseLewis J Rubin, Carol M Black, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|September 27, 2013
Treatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trialN P Quillinan, D McIntosh, J Vernes, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimicCarolina Teles, Chiranthi Kongala Liyanage, Geoffrey Chow, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Physician-patient communication in the treatment of systemic sclerosis-associated interstitial lung disease: A narrative review and recommendationsMasataka Kuwana, Aiko Saito, Sue Farrington, et al.
Pageof 61